Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iridium-catalyzed asymmetric synthesis offers high ee values. Enhances supply chain reliability for pharmaceutical intermediates manufacturing. Supports commercial scale-up of complex pharmaceutical intermediates with stringent purity.
Patent CN118126005B reveals metal-free synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalability.
Novel metal-free method for trifluoroacetimide dihydrobenzofuran. High stereoselectivity, air atmosphere, cost-effective for pharmaceutical intermediates manufacturing.
Patent CN107163062A reveals mild sulphonyl lactone synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity and scalability.
Patent CN113511986B reveals a green catalyst-free method for aryl acetonitrile derivatives. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel patent CN118126005B details metal-free synthesis of fluorinated heterocycles. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN118271227B reveals silver-catalyzed synthesis for high-purity pyrrole intermediates offering cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN113735778B reveals efficient silver oxide catalysis for high-purity imidazole manufacturing. Achieve substantial cost reduction and supply chain reliability.
Patent CN110963943B details a mild, high-yield one-pot method for aryl amidines using nitrones and isocyanates, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN108794412B details a high-yield base-promoted cyclization for triazoles, offering significant cost reduction in API manufacturing and superior purity profiles.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.
Patent CN115785122A reveals a novel Lewis acid-catalyzed route to indole-piperidine scaffolds with high diastereoselectivity and potent MCF-7 cytotoxicity, offering a scalable solution for API manufacturing.
Patent CN118126005B reveals metal-free synthesis for fluorinated intermediates. Enables cost reduction and scalable supply for pharmaceutical manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and scalable production.
Novel patent CN117263870B offers high-yield Resmetirom intermediate synthesis. Eliminates expensive reagents, ensures supply stability for pharmaceutical manufacturing.
Novel Mo/Cu co-catalyzed method for trifluoromethyl triazoles offers mild conditions and high yields for reliable API intermediate supply chains.
Novel silver oxide promoted synthesis route for high purity pharmaceutical intermediates offering significant cost reduction and supply chain reliability for global buyers.
Novel copper-catalyzed route for allene thioethers offers mild conditions and high yields, ensuring reliable supply chain for complex API synthesis.
Patent CN113735778B reveals Ag2O promoted synthesis. High yield scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.